Aripiprazole and Janumet drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aripiprazole (aripiprazole) and Janumet (metformin hydrochloride; sitagliptin phosphate). Common drug interactions include chronic kidney disease among females and sleep disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Aripiprazole and Janumet. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Aripiprazole?

Aripiprazole has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 39,143 Aripiprazole users. Check the latest studies of Aripiprazole.

What is Janumet?

Janumet has active ingredients of metformin hydrochloride; sitagliptin phosphate. It is often used in diabetes. eHealthMe is studying from 25,023 Janumet users. Check the latest studies of Janumet.



On Jul, 20, 2026

38 people who take Aripiprazole and Janumet together, and have interactions are studied.

Aripiprazole and Janumet drug interactions.

What are the common drug interactions of Aripiprazole and Janumet, by gender? *:

female:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Uterine cancer
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Diarrhoea
  6. Gastrointestinal viral infection (virus infection of gastrointestinal tract)
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Herpes zoster
  9. Nausea (feeling of having an urge to vomit)
  10. Pulmonary embolism (blockage of the main artery of the lung)

male:

  1. Sleep disorder
  2. Bacteraemia (presence of bacteria in the blood)
  3. Dry eye (lack of adequate tears)
  4. Fall
  5. Gait disturbance
  6. Hospitalisation
  7. Hyperhidrosis (abnormally increased sweating)
  8. Hypoxic-ischaemic encephalopathy (a condition that occurs when the entire brain is deprived of an adequate oxygen supply, but the deprivation isn't total)
  9. Initial insomnia (feeling of inadequate or poor-quality sleep)
  10. Klebsiella infection

What are the common drug interactions of Aripiprazole and Janumet, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Bacteraemia (presence of bacteria in the blood)
  2. Electrolyte imbalance
  3. Intestinal pseudo-obstruction (syndrome caused by severe impairment in the ability of the intestines to push food through)
  4. Metabolic disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues)

40-49:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Chronic kidney disease
  3. Diarrhoea
  4. Gastrointestinal viral infection (virus infection of gastrointestinal tract)
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Herpes zoster
  7. Nausea (feeling of having an urge to vomit)
  8. Viral infection
  9. Vomiting
  10. Renal failure (kidney dysfunction)

50-59:

  1. Abdominal pain
  2. Chronic kidney disease
  3. Delusion (a false belief or opinion)
  4. Disease progression
  5. Fall
  6. Gait disturbance
  7. Hepatitis (inflammation of the liver)
  8. Hospitalisation
  9. Klebsiella infection
  10. Myocarditis (inflammation of heart muscle myocardium)

60+:

  1. Uterine cancer
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Overdose
  4. Pneumonia
  5. Portal hypertension (increase in the blood pressure within a system of veins called the portal venous system)
  6. Insomnia (sleeplessness)
  7. Sleep disorder
  8. Somnolence (a state of near-sleep, a strong desire for sleep)
  9. Terminal insomnia (a sleep disorder in which there is an inability to fall asleep or to stay asleep as long as desired)
  10. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 13 people, 34.21%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 31.58%
  3. Cardiac Disorder: 10 people, 26.32%
  4. Pain: 10 people, 26.32%
  5. Infection: 10 people, 26.32%
  6. Stress And Anxiety: 10 people, 26.32%
  7. High Blood Pressure: 9 people, 23.68%
  8. Bipolar Disorder (mood disorder): 8 people, 21.05%
  9. Muscle Spasms (muscle contraction): 8 people, 21.05%
  10. Hypersensitivity: 8 people, 21.05%

* Approximation only. Some reports may have incomplete information.

Do you take Aripiprazole and Janumet?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Aripiprazole and Janumet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aripiprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Janumet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aripiprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Janumet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole and metformin hydrochloride; sitagliptin phosphate (the active ingredients of Aripiprazole and Janumet, respectively), and Aripiprazole and Janumet (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: